IMAC Holdings, Inc. (OTCPK: BACK)
Health Care · Biotechnology · US
$0.00
+20.00% today · -99.2% 1Y
IMAC Holdings, Inc. (OTCPK: BACK) operates in the Biotechnology industry within the Health Care sector. The company is valued at $2.27K and employs 15 people.
Over the last twelve months the share price has lost 99.2%, trading between 0.00 and 0.21.
Tweenvest scores IMAC Holdings, Inc. across four factors: quality 19/100, value 34/100. Its strongest factor is value.
BACK price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.27K
- Revenue (TTM)
- $22.72K
- P/E
- —
- EPS
- -4.48
- Dividend yield
- —
- Beta (5Y)
- 2.00
- 52-week high
- $0.21
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 3.79M
- Employees
- 15
- Next earnings
- —
About IMAC Holdings, Inc.
IMAC Holdings, Inc. operates a network of advanced medical and regenerative care facilities across the United States. Through its outpatient clinics, the company delivers a range of regenerative, orthopedic, and minimally invasive treatments. These services target individuals suffering from various ailments, including sports-related injuries, damage to ligaments and tendons, other soft tissue issues, and chronic pain in the back, knees, and other joints. Additionally, IMAC offers physical therapy, spinal decompression, and chiropractic manipulation. Currently, IMAC Holdings oversees 15 outpatient medical centers situated in six states: Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. Established in 2000, IMAC Holdings, Inc. maintains its corporate headquarters in Brentwood, Tennessee.
- ISIN
- US44967K3023
- Founded
- 2000
- Listed since
- Feb 13, 2019
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Anthera Pharmaceuticals, Inc.OTCPK: ANTH | $2.62K | $0.00 | — |
| TetraLogic Pharmaceuticals CorporationOTCPK: TLOG | $2.43K | $— | — |
| OncoVista Innovative Therapies, Inc.OTCPK: OVIT | $2.36K | $— | — |
| Lipella Pharmaceuticals Inc.OTCPK: LIPO | $2.31K | $0.00 | -98.47% |
| Evelo Biosciences, Inc.OTCPK: EVLO | $1.90K | $0.00 | — |
| RegeneRx Biopharmaceuticals, Inc.OTCPK: RGRX | $1.66K | $— | — |
| Evolutionary Genomics, Inc.OTCPK: FNAM | $1.33K | $— | — |
| GlobeStar Therapeutics CorporationOTCPK: GSTC | $1.24K | $— | — |
Figures last refreshed Oct 4, 2026.